कौन ज़िम्मेदार? KaunZimmedar
BrowseSEBI › regulatory order

CONFIRMATORY ORDER IN THE MATTER OF PAR DRUGS AND CHEMICALS LIMITED

SEBI closed 2026
Plain-language summary (AI-generated) — a quick read so you don't have to open the full PDF. May contain errors; the original document below is authoritative.

What is this order about?

SEBI's confirmatory order addresses Par Drugs and Chemicals Limited (PDCL) for alleged non-compliance with securities regulations regarding a slump sale transaction involving its core business to a promoter-related entity, Phal-Jig Fine Chemicals Private Limited (PJFCPL).

Who it concerns

Par Drugs and Chemicals Limited (PDCL), Phal-Jig Fine Chemicals Private Limited (PJFCPL)

What was found or directed

  • SEBI found PDCL's valuation method for slump sale did not account for intangibles, employees, goodwill, and business as a going concern
  • Valuation reports did not specify valuation for slump sale of a profitable going concern
  • PDCL failed to provide a fairness opinion as claimed in EGM notice
  • SEBI noted the transaction could have caused grave injustice to public shareholders due to undervaluation
Source bodySecurities & Exchange Board of India (SEBI) — enforcement orders
Reference numberWTM/KV/CFID/CFID-SEC4/32246/2025-26
Statusclosed (section: order)
Year2026
Closing date
Documents1

Highlights & Points worth asking

Auto-generated, neutral observations. Auto-generated from public documents. May contain errors. Not legal or financial advice. Always verify against the linked original document. KaunZimmedar is a platform, not an authority.

No automated observations for this document. Read the documents below directly.

Documents

The original government PDF is the authoritative source — shown below, or open it full-screen in a new tab.

Order 2026-03-25 ORDER_1774324130.pdf
Tap “Open the PDF” above to view this document.

Discussion (0)

Citizens discussing these documents. A discussion space — nothing here is verified fact or an official finding. Reading is free; sign in to take part.

Open discussion (0) →